| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Yingying Le | Q39854972 |
| P2093 | author name string | Philip M Murphy | |
| Ji Ming Wang | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 541-548 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Trends in Immunology | Q15265730 |
| P1476 | title | Formyl-peptide receptors revisited | |
| P478 | volume | 23 |
| Q54438900 | A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. |
| Q40343332 | A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells |
| Q90651233 | A long-lived peptide-conjugated iridium(iii) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2 |
| Q41829746 | A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand |
| Q33372612 | A systems biology approach to construct the gene regulatory network of systemic inflammation via microarray and databases mining |
| Q36482989 | A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases. |
| Q40341534 | Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. |
| Q40092966 | Activation of the human FPRL-1 receptor promotes Ca2+ mobilization in U87 astrocytoma cells |
| Q28256027 | Adaptive evolution of formyl peptide receptors in mammals |
| Q36165863 | An overview of the effects of annexin 1 on cells involved in the inflammatory process |
| Q40235589 | Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent beta-arrestin association and indices of inflammation |
| Q93499076 | Anaphylatoxin and formyl peptide |
| Q35168237 | Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1 |
| Q38125652 | Annexin 1: a glucocorticoid-inducible protein that modulates inflammatory pain |
| Q38305975 | Annexin A1 in primary tumors promotes melanoma dissemination. |
| Q41834792 | Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling |
| Q36497289 | Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair |
| Q38846007 | Annexin A1: shifting the balance towards resolution and repair |
| Q24305148 | Annexin-1 modulates T-cell activation and differentiation |
| Q47158605 | Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment |
| Q55714697 | Annexins in Translational Research: Hidden Treasures to Be Found. |
| Q34095174 | Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation |
| Q79314449 | Antiflammin-2 activates the human formyl-peptide receptor like 1 |
| Q40170667 | Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities |
| Q36078499 | Antimicrobial peptide scolopendrasin VII, derived from the centipede Scolopendra subspinipes mutilans, stimulates macrophage chemotaxis via formyl peptide receptor 1. |
| Q33947942 | Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin |
| Q100559255 | Application of small molecule FPR1 antagonists in the treatment of cancers |
| Q44820320 | Arrestins block G protein-coupled receptor-mediated apoptosis |
| Q48369250 | Aspirin and (or) omega-3 polyunsaturated fatty acids protect against corticohippocampal neurodegeneration and downregulate lipoxin A4 production and formyl peptide receptor-like 1 expression in pentylenetetrazole-kindled rats. |
| Q28191625 | BLT1 and BLT2: the leukotriene B(4) receptors |
| Q37173782 | Bacteria activate sensory neurons that modulate pain and inflammation |
| Q39075039 | Bacterial Signaling to the Nervous System through Toxins and Metabolites |
| Q28573059 | Beta-amyloid peptide stimulates endozepine release in cultured rat astrocytes through activation of N-formyl peptide receptors |
| Q37718243 | Bile acids: short and long term effects in the intestine. |
| Q44636975 | Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1. |
| Q34014452 | Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation. |
| Q57016985 | Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform |
| Q35292194 | Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour. |
| Q52927291 | Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. |
| Q36545368 | Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages |
| Q34194202 | Characterization of Fpr-rs8, an atypical member of the mouse formyl peptide receptor gene family |
| Q35573448 | Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells |
| Q92128444 | Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors |
| Q36403878 | Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. |
| Q35925892 | Chemotaxis receptors and signaling |
| Q35887290 | Chemotaxis: signalling the way forward |
| Q58792300 | Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction |
| Q34193117 | Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors. |
| Q36064465 | Controlling inflammation: a fat chance? |
| Q57021966 | Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin |
| Q33672477 | Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1. |
| Q55487169 | Crotoxin Isolated from Crotalus durissus terrificus Venom Modulates the Functional Activity of Dendritic Cells via Formyl Peptide Receptors. |
| Q35621562 | Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes |
| Q50776413 | Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. |
| Q38025082 | Danger signals activating the immune response after trauma |
| Q90292812 | Deficiency in Fpr2 results in reduced numbers of Lin-cKit+Sca1+ myeloid progenitor cells |
| Q44915635 | Design of soymetide-4 derivatives to potentiate the anti-alopecia effect |
| Q35071380 | Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition. |
| Q33368728 | Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes |
| Q47732447 | Effects of isoflurane and sevoflurane on the neutrophil myeloperoxidase system of horses |
| Q38298369 | Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors |
| Q28727788 | Enterococcus faecium stimulates human neutrophils via the formyl-peptide receptor 2 |
| Q35498598 | Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages |
| Q36118080 | Essential role of protein kinase C zeta in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP. |
| Q35946992 | Exocytosis of Neutrophil Formyl peptide receptor-like 1 (fPRL1) results in downregulation of cytoplasmic fPRL1 in patients with purulent dermatitis |
| Q37618896 | Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics |
| Q52718771 | Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer. |
| Q36085062 | FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages |
| Q34718497 | FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. |
| Q90168522 | FPR1 is the plague receptor on host immune cells |
| Q33784587 | FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients |
| Q43151927 | FPRs: linking innate immune system and fibrosis |
| Q55010992 | Formyl Peptide Receptor 1 Modulates Endothelial Cell Functions by NADPH Oxidase-Dependent VEGFR2 Transactivation. |
| Q90265963 | Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma |
| Q37146198 | Formyl Peptide Receptor Activation Elicits Endothelial Cell Contraction and Vascular Leakage |
| Q39079401 | Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases. |
| Q90483887 | Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair |
| Q38907435 | Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015). |
| Q28242233 | Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors |
| Q35844396 | Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides |
| Q33670941 | Formyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signaling |
| Q55397071 | Formyl-Peptide Receptor Agonists and Amorphous SiO2-NPs Synergistically and Selectively Increase the Inflammatory Responses of Human Monocytes and PMNs. |
| Q36711055 | Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells |
| Q36733448 | Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. |
| Q34310804 | Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes. |
| Q35112909 | Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing |
| Q28585572 | Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation |
| Q28279407 | Functional characterization of three mouse formyl peptide receptors |
| Q37011702 | Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists |
| Q93551696 | G Protein-Coupled Receptors |
| Q40325163 | G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils |
| Q37175083 | G-protein coupled chemoattractant receptors and cancer |
| Q37635259 | GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation |
| Q38317059 | Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study |
| Q46011691 | Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. |
| Q39975456 | Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. |
| Q39608604 | HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes. |
| Q89543967 | Hematopoietic cell-derived RELMα regulates hookworm immunity through effects on macrophages |
| Q42045762 | High-content screening: flow cytometry analysis |
| Q48595483 | High-throughput flow cytometry for drug discovery |
| Q38656461 | Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1. |
| Q36375986 | Human Neutrophil Chemotaxis Is Modulated by Capsule and O Antigen from an Extraintestinal PathogenicEscherichia coliStrain |
| Q33982401 | Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils |
| Q45967303 | Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels. |
| Q36157687 | Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus |
| Q28262329 | Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR |
| Q73468534 | Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket |
| Q34677680 | Hyperosmolar stress induces neutrophil extracellular trap formation: implications for dry eye disease |
| Q38333675 | IL-10 stimulatory effects on human NK cells explored by gene profile analysis |
| Q28300408 | Identification and characterization of an endogenous chemotactic ligand specific for FPRL2 |
| Q33402646 | Identification in milk of a serum amyloid A peptide chemoattractant for B lymphoblasts. |
| Q37250080 | Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils |
| Q34409580 | Identification of genes potentially involved in disease transformation of CML. |
| Q30881148 | Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition. |
| Q35082519 | Identification of systemic immune response markers through metabolomic profiling of plasma from calves given an intra-nasally delivered respiratory vaccine. |
| Q38993390 | Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents. |
| Q33419375 | Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways |
| Q50884236 | Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. |
| Q81224617 | In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b |
| Q38763491 | Infection, Pain, and Itch |
| Q35770168 | Inflammatory resolution: new opportunities for drug discovery |
| Q37629888 | Innate Immune Activity in Glomerular Podocytes |
| Q35179622 | Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation |
| Q35134687 | Innate immunity and pathogen-host interaction |
| Q36008864 | Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. |
| Q36276594 | Interleukin-10 and the immune response against cancer: a counterpoint |
| Q24652940 | International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family |
| Q36724806 | Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis |
| Q57794157 | Intratracheal transplantation of mesenchymal stem cells attenuates hyperoxia-induced lung injury by down-regulating, but not direct inhibiting formyl peptide receptor 1 in the newborn mice |
| Q28570305 | Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells |
| Q48765280 | Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis |
| Q35068536 | Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species |
| Q41849128 | Lysophosphatidylglycerol inhibits formyl peptide receptorlike-1-stimulated chemotactic migration and IL-1beta production from human phagocytes |
| Q97418489 | MTFMT deficiency correlates with reduced mitochondrial integrity and enhanced host susceptibility to intracellular infection |
| Q37045743 | Macrophage activation by endogenous danger signals |
| Q26741609 | Mechanisms of Aβ Clearance and Degradation by Glial Cells |
| Q26992155 | Mechanisms of epithelial wound detection |
| Q41014561 | Microglia function in Alzheimer's disease |
| Q38754086 | Mitochondrial DNA in Sepsis |
| Q59806790 | Mitochondrial Damage-Associated Molecular Patterns of Injured Axons Induce Outgrowth of Schwann Cell Processes |
| Q55025737 | Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases. |
| Q35275433 | Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome |
| Q33576761 | Mitochondrial damage-associated molecular patterns and vascular function |
| Q38645639 | Mitochondrial protein-derived cryptides: Are endogenous N-formylated peptides including mitocryptide-2 components of mitochondrial damage-associated molecular patterns? |
| Q47841934 | Modeling of granulocyte cytoskeletal responses following fMLP challenging. |
| Q53646664 | Modulation of bone marrow-derived neutrophil signaling by H2O2: disparate effects on kinases, NF-kappaB, and cytokine expression. |
| Q40846156 | Modulation of neutrophil apoptosis by antimicrobial peptides |
| Q83068078 | Molecular and evolutionary analyses of formyl peptide receptors suggest the absence of VNO-specific FPRs in primates |
| Q34327503 | Molecular biology for formyl peptide receptors in human diseases |
| Q42554282 | Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors |
| Q33426364 | Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils |
| Q52718407 | N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor. |
| Q34948033 | N-formyl-methionyl-leucyl-phenylalanine (fMLP) promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow |
| Q92219965 | NOX2-Dependent Reactive Oxygen Species Regulate Formyl-Peptide Receptor 1-Mediated TrkA Transactivation in SH-SY5Y Cells |
| Q37218225 | Neisseria gonorrhoeae suppresses the oxidative burst of human polymorphonuclear leukocytes |
| Q49571565 | Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms |
| Q28205486 | Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1 |
| Q36570742 | New development in studies of formyl-peptide receptors: critical roles in host defense |
| Q51038545 | Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production. |
| Q39660802 | Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. |
| Q40545700 | Normal cell surface expression and selective loss of functions resulting from Phe110 to Ser and Cys126 to Trp substitutions in the formyl peptide receptor |
| Q35738729 | Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2 |
| Q35733803 | Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics |
| Q38166623 | Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors |
| Q38167648 | Pattern recognition receptors in innate immunity, host defense, and immunopathology |
| Q43775557 | PepT1 expressed in immune cells has an important role in promoting the immune response during experimentally induced colitis |
| Q45189695 | Phagocyte function |
| Q80260250 | Pharmacophore model for bile acids recognition by the FPR receptor |
| Q34555295 | Physiological characterization of formyl peptide receptor expressing cells in the mouse vomeronasal organ |
| Q38815457 | Pleiotropic regulations of neutrophil receptors response to sepsis |
| Q92465935 | Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment |
| Q97067634 | Primary Immunodeficiencies With Defects in Innate Immunity: Focus on Orofacial Manifestations |
| Q28476523 | Production of a bioengineered G-protein coupled receptor of human formyl peptide receptor 3 |
| Q39506338 | Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells. |
| Q44523487 | Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide |
| Q38859451 | Radiosynthesis and in vivo Evaluation of Carbon-11 (2S)-3-(1H-Indol-3-yl)-2-{[(4-methoxyphenyl)carbamoyl]amino}-N-{[1-(5-methoxypyridin-2-yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of Neu |
| Q30632627 | Rapid scanning structure-activity relationships in combinatorial data sets: identification of activity switches |
| Q34313996 | Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression |
| Q34426368 | Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat |
| Q27313685 | Recognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens |
| Q34928547 | Redox signaling mediated by the gut microbiota |
| Q35790849 | Regulation of haematopoiesis by growth factors - emerging insights and therapies |
| Q39423782 | Regulation of inflammation by members of the formyl-peptide receptor family |
| Q37090449 | Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation |
| Q33683537 | Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas. |
| Q30479630 | Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils |
| Q90454840 | Role of Signaling Molecules in Mitochondrial Stress Response |
| Q36124489 | Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease |
| Q34974195 | Scant Extracellular NAD Cleaving Activity of Human Neutrophils is Down-Regulated by fMLP via FPRL1. |
| Q34780074 | Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries |
| Q39759473 | Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes. |
| Q46271764 | Sevoflurane modulates the release of reactive oxygen species, myeloperoxidase, and elastase in human whole blood: Effects of different stimuli on neutrophil response to volatile anesthetic in vitro |
| Q57150089 | Signal detection and coding in the accessory olfactory system |
| Q36910018 | Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation |
| Q33719408 | Staphylococcus epidermidis strategies to avoid killing by human neutrophils |
| Q53507643 | Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm. |
| Q92757292 | Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity |
| Q53448225 | Sustained monocyte activation in clinical remission of systemic vasculitis. |
| Q37387241 | Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells |
| Q36590244 | Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists |
| Q42244148 | T4-lysozyme fusion for the production of human formyl peptide receptors for structural determination |
| Q64991299 | Targeting Endothelial Barrier Dysfunction Caused by Circulating Bacterial and Mitochondrial N-Formyl Peptides With Deformylase. |
| Q37231731 | Targeting bile-acid signalling for metabolic diseases |
| Q47140492 | Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells. |
| Q50026790 | The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q33918314 | The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer |
| Q37447912 | The G-protein coupled chemoattractant receptor FPR2 promotes malignant phenotype of human colon cancer cells |
| Q30493852 | The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells |
| Q92794066 | The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction |
| Q91876323 | The Role of Formyl Peptide Receptor 1 Gene Polymorphisms in Human Colorectal Cancer |
| Q28396823 | The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases |
| Q37097423 | The association between self-reported tooth loss and cognitive function in the Reasons for Geographic And Racial Differences in Stroke study: an assessment of potential pathways |
| Q36832832 | The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation |
| Q35082232 | The bile acid membrane receptor TGR5: a valuable metabolic target |
| Q39640346 | The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. |
| Q24602234 | The emerging role of the mitochondrial-derived peptide humanin in stress resistance |
| Q38952582 | The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis. |
| Q33792925 | The formylpeptide receptor 2 (Fpr2) and its endogenous ligand cathelin-related antimicrobial peptide (CRAMP) promote dendritic cell maturation. |
| Q39854708 | The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. |
| Q35206959 | The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors |
| Q46651587 | The immunostimulatory peptide WKYMVm-NH activates bone marrow mouse neutrophils via multiple signal transduction pathways |
| Q36624209 | The major leukocyte chemotactic and activating factors in the mouse gut lumen are not N-formylpeptide receptor 1 agonists. |
| Q36465426 | The oligopeptide transporter hPepT1: gateway to the innate immune response |
| Q38057219 | The plasminogen system in regulating stem cell mobilization |
| Q64982025 | The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice. |
| Q33993124 | The role of chemoattractant receptors in shaping the tumor microenvironment. |
| Q92932494 | The sensing of mitochondrial DAMPs by non-immune cells |
| Q24808945 | The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide |
| Q39030266 | The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface |
| Q39539331 | Thymosin α 1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis |
| Q28218287 | Uneven modulation of the annexin 1 system in osteoblast-like cells by dexamethasone |
| Q28480492 | Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis |
| Q35768177 | Uteroglobin suppresses allergen-induced TH2 differentiation by down-regulating the expression of serum amyloid A and SOCS-3 genes |
| Q37693893 | Uteroglobin, a possible ligand of the lipoxin receptor inhibits serum amyloid A-driven inflammation. |
| Q36783290 | V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins |
| Q35024932 | WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells |
| Q39167016 | WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A. |
| Q46416634 | f-Met-Leu-Phe stimulates nitric oxide production in chick embryo neurons: the role of NF-kB. |
| Q89160586 | fMLP-dependent activation of Akt and ERK1/2 through ROS/Rho A pathways is mediated through restricted activation of the FPRL1 (FPR2) receptor |
| Q40299179 | hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes |
Search more.